Home >  Investors Relations >  CryoLife Reports Preliminary Financial Results for Third Quarter 2018 in Anticipation of Discussions with Senior Lenders Regarding Repricing Senior Credit Facility

CryoLife to Present at 38th Annual Canaccord Genuity Growth Conference

July 26, 2018 at 8:30 AM EDT

ATLANTA, July 26, 2018 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 38th Annual Canaccord Genuity Growth Conference on Thursday, August 9, 2018 at the InterContinental Boston Hotel.

Cryolife logo. (PRNewsFoto/CryoLife, Inc.) (PRNewsFoto/CRYOLIFE_ INC_) (PRNewsFoto/CRYOLIFE, INC.)

A live webcast of the Company's presentation is scheduled to begin at 11:30 a.m. ET and will feature an overview of the company by Pat Mackin, Chairman, President and Chief Executive Officer.

The live webcast can be accessed through CryoLife's website, www.cryolife.com, on the Investor Relations page.  An archived copy of the webcast will be available for 90 days on the same website.

About CryoLife, Inc.

Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair.  CryoLife markets and sells products in more than 90 countries worldwide.  For additional information about CryoLife, visit our website, www.cryolife.com

Contacts:

CryoLife         

Gilmartin Group LLC

D. Ashley Lee 

Greg Chodaczek / Lynn Lewis

Executive Vice President, Chief Financial Officer

Phone:  646-924-1769

and Chief Operating Officer                         

investors@cryolife.com

Phone: 770-419-3355         


 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/cryolife-to-present-at-38th-annual-canaccord-genuity-growth-conference-300686970.html

SOURCE CryoLife, Inc.